A review of 3D In vitro skin models for psoriasis: from pathophysiology to advanced bioengineering.
- 1Yunnan Botanee Bio-technology Group Co., Ltd., Yunnan, China.
- 2Yunnan Characteristic Plant Extraction Laboratory, Yunnan Characteristic Plant Extraction Laboratory Co., Ltd., Kunming, China.
- 3Shanghai Botanee Bio-technology Co., Ltd., Shanghai, China.
Abstract
Three-dimensional (3D) skin models have become a transformative choice for replacing animal models in psoriasis research. However, the diversity of platforms, from commercial skin equivalents to organ-on-a-chip systems, has rapidly increased, posing a key selection dilemma for researchers. Based on this, we comprehensively classified the models based on their construction strategies and compared their pathological fidelity from six key dimensions: structural complexity, immune integration, vascular or neural function, scalability, primary application and recommended biological composition. Looking back at the development process of in vitro psoriasis models, it can be found that the construction strategy has gradually shifted: from static structural substitutes to dynamic systems that can reproduce natural tissue function. Although commercial models have strong standardization advantages suitable for high-throughput screening, cutting-edge bioengineering platforms including organoids and organ-on-a-chip devices have bridged the gap between laboratory constructs and clinical phenotypes by reconstructing the neural-immune-vascular axis. This review summarizes the latest progress in in vitro psoriasis modeling, explores the bottlenecks that currently exist in the system, and proposes innovative methods to provide new ideas for constructing the next-generation of models that are closer to the pathological characteristics of real psoriasis.
Related
- A Novel Bioengineering Approach to Breast Cancer Invasion In Vitro Through Enhancing the Value of Existing Breast Cancer Epithelial Lineages
- The Association Between Psoriasis and Cardiovascular Comorbidity: A Narrative Review
- Exploring Dietary Supplements for Psoriasis Management: A Narrative Review
- Food-Derived Substances and Edible Chinese Medicinal Materials in Psoriasis Management: Potential, Evidence, and Perspectives-A Narrative Review.
- Adjusted Comparative Treatment Persistence of IL-23p19 Versus IL-17 Pathway Inhibitors in Adults With Plaque Psoriasis: A Systematic Review and Exploratory Meta-analysis of Real-World Time-to-Discontinuation Estimates
BibTeX
@article{cheng2026review,
title = {{A review of 3D In vitro skin models for psoriasis: from pathophysiology to advanced bioengineering.}},
author = {Yuying Cheng and Feifei Wang and Bo Wang},
journal = {Frontiers in bioengineering and biotechnology},
year = {2026},
month = oct,
doi = {10.3389/fbioe.2026.1918162},
url = {https://europepmc.org/article/MED/42899061},
note = {CC BY},
}
RIS
TY - JOUR
TI - A review of 3D In vitro skin models for psoriasis: from pathophysiology to advanced bioengineering.
AU - Yuying Cheng
AU - Feifei Wang
AU - Bo Wang
PY - 2026
DA - 2026/10/05
JO - Frontiers in bioengineering and biotechnology
DO - 10.3389/fbioe.2026.1918162
UR - https://europepmc.org/article/MED/42899061
AB - Three-dimensional (3D) skin models have become a transformative choice for replacing animal models in psoriasis research. However, the diversity of platforms, from commercial skin equivalents to organ-on-a-chip systems, has rapidly increased, posing a key selection dilemma for researchers. Based on this, we comprehensively classified the models based on their construction strategies and compared their pathological fidelity from six key dimensions: structural complexity, immune integration, vascular or neural function, scalability, primary application and recommended biological composition. Looking back at the development process of in vitro psoriasis models, it can be found that the construction strategy has gradually shifted: from static structural substitutes to dynamic systems that can reproduce natural tissue function. Although commercial models have strong standardization advantages suitable for high-throughput screening, cutting-edge bioengineering platforms including organoids and organ-on-a-chip devices have bridged the gap between laboratory constructs and clinical phenotypes by reconstructing the neural-immune-vascular axis. This review summarizes the latest progress in in vitro psoriasis modeling, explores the bottlenecks that currently exist in the system, and proposes innovative methods to provide new ideas for constructing the next-generation of models that are closer to the pathological characteristics of real psoriasis.
SN - 2296-4185
ER -